|
|
FOCUSED NOTE: ALOPECIA (NON-SCARRING)
CHIEF COMPLAINT (C/C) HISTORY OF PRESENT ILLNESS (HPI)
PAST HISTORY Does not report a history of chickenpox measles, mumps, rubella, whooping cough, rheumatic fever, scarlet fever, or polio. Immunization – Hemophilus influenza type B: 4/4 HPV Three dose Series completed 2000 COVID vaccine Completed 11/13/21, 3/15/21. She has not received a booster dose for COVID vaccine. SOCIAL HISTORY GASTROINTESTINAL: Denies abdominal pain, trouble swallowing, heartburn, problem with appetite, nausea, vomiting, regurgitation, vomiting of blood, indigestion, food intolerance, excessive belching, burping, or passing of gas; denies constipation, diarrhea, jaundice, liver or gallbladder trouble, hepatitis. Reports soft brown stool with bowel movements occurring 1-2 times daily. PHYSICAL EXAMINATION VITAL SIGNS: BP: 117/73 (sitting, automatic), P: 98, RR: 20, T: 37.6 Ht: 58 inches Wt: 154 lbs; BMI: 24.3 (the patient indicates that this ranges within her usual weight). EYES: Clear conjunctivae on both eyes. Both eyes are symmetrical. Lids are without drooping or ptosis. Both sclerae are white. No evidence of hemorrhage or exudates. No icterus or muddy appearance on the sclerae, conjunctivae are pale, corneal clear, PERRLA, EOM are intact, light reflex direct and consensual brisk and intact. No swellings of lesion on eye lids. Visual acuity 20/20 bilateral. Optic disc with intact red reflex, optic disc with sharp margin, small central cup, and no edema. Retinal vessels intact, no A/V nicking or cotton wool spots. EARS: Internal and external ears are without edema or tenderness. Both ears are symmetrical and are in line with the outer canthus of the eyes. The pinna can easily be manipulated without difficulties. Rinne test AC>BC. No evidence of obstruction of the ear canals. No evidence of cerumen observed. The tympanic membrane IS pearly grey with good cone of light bilaterally. Weber -midline. Acuity good to whispered voice. NOSE: Nasal mucosa is moist and pink. No evidence of discharge or nasal congestion. Turbinates are neither boggy nor enlarged. The sinuses are non-tender. The nasal septum is intact and positioned midline. MOUTH AND THROAT: The buccal mucosa is moist. The tongue is positioned midline, moist, pink, and without fasciculation. The teeth in good arrangements on the gums. No evidence of cavities. The gum is pink with no evidence of gingivitis or halitosis. No tonsils or erythema observed on the throat. No exudates, lesions, or nodules. The pharynx is pink in appearance. ABDOMEN: Abdomen is soft and protuberant, no scars. Normal bowel sounds active in all four quadrants; No abdominal guarding, or tenderness; Percussion notes tympanic in all four quadrants. No shifting dullness. No tenderness on light and deep palpation Liver, spleen, and kidneys non-palpable. Umbilicus is midline with no evidence of herniation. No abnormal masses observed.
PROBLEM LIST Sudden hair loss Diffuse hair loss on the scalp Non-scaly patches on regions of hair loss on the scalp Absence of scarring in the affected areas of the scalp Hair thinning/broken hair shafts Areas of hair loss are non-erythematous DIFFERENTIAL DIAGNOSIS Lichen planopilaris Stress Anemia Diagnostics -Pregnancy test -Psychological assessment to determine the degree of stress, the source of a stressful events, and use of hair products -Pull test to establish whether there is evidence of active hair shedding
MEDICATION -Intralesional triamcinolone acetonide injected intradermally -2% solution of topical minoxidil
REFERRAL: -Gynecologist -Dermatologist
Follow UP in 2 weeks: PATIENT EDUCATION Your primary diagnosis is non-scarring type of alopecia. Alopecia is a disease condition in which patients present with hair loss on the scalp. It is called nonscarring type because there is lack of scars on the areas of hair loss. Non-scarring alopecia may be triggered by numerous factors including stress, exposure to chemical agents, use of strong hair products, hormonal imbalance, or pregnancy-related reactions in women (Poonia et al., 2020). Non-scarring alopecia is reversible, especially when appropriate treatment is started early. Patients with non-scarring alopecia usually experience mild itchiness on the scalp characterized by hair loss which may be focal or diffuse. Hair thinning and softness are additional symptoms that are usually experienced by people non-scarring alopecia. In non-scarring alopecia, regions of hair loss can form non-scaly patches but are usually non-erythematous. Your alopecia may be attributed to a recent event of stress that are reportedly experiencing, hormonal changes, some cosmetic products that you are currently using on your hair, or exposure to some chemical agents that you might not be aware of (Oner & Akdeniz, 2021). Such substances usually cause hair non-scarring hair loss, especially in females You will be treated with intralesional triamcinolone acetonide intradermally to help relieve disease symptoms (American Academy of Family Physicians, 2020; Kapoor et al., 2020). You will also be given a 2% solution of topical minoxidil that you will be required to apply on your scalp twice a day for two weeks before visiting the hospital again (Wall et al., 2022). You will be referred today to a psychiatrist to assess the level and potential impact of your stress. Additionally, you will need to visit a dermatologist who should conduct a further assessment to establish possible causes of your alopecia and to recommend the most appropriate interventions. You will also need to visit a gynecologist to assess if there is an imbalance in the levels of your sex hormones. You are advised to engage in physical activity and consume a diet that is rich in proteins, fruits, and vegetables (Trueb, 2021). Feel free to reach the clinic using the number provided in your forms if you experiencing problematic symptoms. References American Academy of Family Physicians. (2020). Hair loss: Common causes and treatment. https://www.aafp.org/afp/2017/0915/p371.html Kapoor, P., Kumar, S., Brar, B. K., Kukar, N., Arora, H., & Brar, S. K. (2020). Comparative evaluation of therapeutic efficacy of intralesional injection of triamcinolone acetonide versus intralesional autologous platelet-rich plasma injection in alopecia areata. Journal of Cutaneous and Aesthetic Surgery, 13(2), 103–111. https://doi.org/10.4103/JCAS.JCAS_16_19 Öner, Ü., & Akdeniz, N. (2021). Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom? Turkish Journal of Medical Sciences, doi: 10.3906/sag-2106-28. Epub ahead of print. PMID: 34688244. Poonia, K., Thami, G. P., Bhalla, M., Jaiswal, S., & Sandhu, J. (2020). Non-scarring diffuse hair loss in women: a clinico-etiological study from tertiary care center in North-West India. Journal of Cosmetic Dermatology, 18(1):401-407. doi: 10.1111/jocd.12559. Epub 2018 May 17. PMID: 29774652. Trüeb R. M. (2021). “Let Food be Thy Medicine”: Value of nutritional treatment for hair loss. International Journal of Trichology, 13(6), 1–3. https://doi.org/10.4103/ijt.ijt_124_20 Wall, D., Meah, N., Fagan, N., York, K., & Sinclair, R. (2022). Advances in hair growth. Faculty Reviews, 11, 1. https://doi.org/10.12703/r/11-1 |